These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 403278)

  • 21. Pharmacokinetics and bioavailability of cephalothin in horse mares.
    Ruoff WW; Sams RA
    Am J Vet Res; 1985 Oct; 46(10):2085-90. PubMed ID: 4062011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chloroquine kinetics in normal and P. knowlesi infected rhesus monkeys.
    Prasad RN; Garg SK; Mahajan RC; Ganguly NK
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):302-4. PubMed ID: 4018930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of quinidine and three of its metabolites in man.
    Rakhit A; Holford NH; Guentert TW; Maloney K; Riegelman S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):1-21. PubMed ID: 6747817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous administration of prostacyclin in rabbits: elimination kinetics and blood pressure response.
    Skrinska VA; Lucas FV; Chisolm GM; Hesse BL
    J Lab Clin Med; 1986 Mar; 107(3):187-93. PubMed ID: 3512745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction effect of phenobarbital on the carbamazepine to carbamazepine-10, 11-epoxide pathway in rhesus monkeys.
    Patel IH; Wedlund P; Levy RH
    J Pharmacol Exp Ther; 1981 Jun; 217(3):555-8. PubMed ID: 7229992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced quinidine clearance in elderly persons.
    Ochs HR; Greenblatt DJ; Woo E; Smith TW
    Am J Cardiol; 1978 Sep; 42(3):481-5. PubMed ID: 356577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of quinidine with anticonvulsant drugs.
    Data JL; Wilkinson GR; Nies AS
    N Engl J Med; 1976 Mar; 294(13):699-702. PubMed ID: 1250281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition kinetics of two oral forms of quinidine.
    Mahon WA; Mayersohn M; Inaba T
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):566-75. PubMed ID: 1277713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative bioavailability and pharmacokinetic studies of azathioprine and 6-mercaptopurine in the rhesus monkey.
    Ding TL; Benet LZ
    Drug Metab Dispos; 1979; 7(6):373-7. PubMed ID: 43222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of quinidine metabolism and plasma protein binding by phenobarbital in dogs.
    Rakhit A; Holford NH; Effeney DJ; Riegelman S
    J Pharmacokinet Biopharm; 1984 Oct; 12(5):495-515. PubMed ID: 6520745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absolute quinidine bioavailability.
    Ueda CT; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Sep; 20(3):260-5. PubMed ID: 954347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impairment of digoxin clearance by coadministration of quinidine.
    Ochs HR; Bodem G; Greenblatt DJ
    J Clin Pharmacol; 1981 Oct; 21(10):396-400. PubMed ID: 7309901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative disposition kinetics of two diastereomeric pairs of cinchona alkaloids in the dog.
    Abraham I; Ueda CT
    J Pharm Sci; 1984 Apr; 73(4):452-6. PubMed ID: 6726627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-dependent kinetics I: Exponential autoinduction of carbamazepine in monkeys.
    Pitlick WH; Levy RH
    J Pharm Sci; 1977 May; 66(5):647-9. PubMed ID: 406378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of pharmacokinetic parameters of intravenous quinidine and quinine in dogs.
    Clohisy DR; Gibson TP
    J Cardiovasc Pharmacol; 1982; 4(1):107-10. PubMed ID: 6176784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies.
    Guentert TW; Holford NH; Coates PE; Upton RA; Riegelman S
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):315-30. PubMed ID: 512840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration.
    Ueda CT; Dzindzio BS
    Eur J Clin Pharmacol; 1979 Sep; 16(2):101-5. PubMed ID: 499305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.